Outcomes of Patients with Advanced Hepatocellular Carcinoma Receiving Lenvatinib following Immunotherapy: A Real World Evidence Study

por Palmer, Mathias E., Gile, Jennifer J., Storandt, Michael H., Jin, Zhaohui, Zemla, Tyler J., Tran, Nguyen H., Mahipal, Amit
Publicado 2023

Cabozantinib Following Immunotherapy in Patients with Advanced Hepatocellular Carcinoma

por Storandt, Michael H., Gile, Jennifer J., Palmer, Mathias E., Zemla, Tyler J., Ahn, Daniel H., Bekaii-Saab, Tanios S., Jin, Zhaohui, Tran, Nguyen H., Mahipal, Amit
Publicado 2022

Evaluating the Significance of Pancreatobiliary Fluorescence In Situ Hybridization Polysomy on Prognosis in De Novo Cholangiocarcinoma

por Ji, Hyun, Barr Fritcher, Emily G., Yin, Jun, Bainter, Tiffany M., Zemla, Tyler J., Gores, Gregory J., Halling, Kevin C., Kipp, Benjamin R., Roberts, Lewis R.
Publicado 2022

Association between physical activity and the time course of cancer recurrence in stage III colon cancer

por Brown, Justin C, Ma, Chao, Shi, Qian, Niedzwiecki, Donna, Zemla, Tyler, Couture, Felix, Kuebler, Philip, Kumar, Pankaj, Hopkins, Judith O, Tan, Benjamin, Krishnamurthi, Smitha, O'Reilly, Eileen M, Shields, Anthony F, Meyerhardt, Jeffrey A
Publicado 2023

Contribution of Immunoscore and Molecular Features to Survival Prediction in Stage III Colon Cancer

por Sinicrope, Frank A, Shi, Qian, Hermitte, Fabienne, Zemla, Tyler J, Mlecnik, Bernhard, Benson, Al B, Gill, Sharlene, Goldberg, Richard M, Kahlenberg, Morton S, Nair, Suresh G, Shields, Anthony F, Smyrk, Thomas C, Galon, Jerome, Alberts, Steven R
Publicado 2020

Older‐Patient‐Specific Cancer Trials: A Pooled Analysis of 2,277 Patients (A151715)

por Dao, Dyda, Zemla, Tyler, Jatoi, Aminah, Freedman, Rachel A., Hurria, Arti, Muss, Hyman, Cohen, Harvey Jay, Shulman, Lawrence N., Citron, Marc, Budman, Daniel, McMurray, Ryan, Partridge, Ann, Carey, Lisa, Sedrak, Mina S., Lafky, Jacqueline M., Le‐Rademacher, Jennifer G.
Publicado 2019

Assessment of Capecitabine and Bevacizumab With or Without Atezolizumab for the Treatment of Refractory Metastatic Colorectal Cancer: A Randomized Clinical Trial

por Mettu, Niharika B., Ou, Fang-Shu, Zemla, Tyler J., Halfdanarson, Thorvardur R., Lenz, Heinz-Josef, Breakstone, Rimini A., Boland, Patrick M., Crysler, Oxana V., Wu, Christina, Nixon, Andrew B., Bolch, Emily, Niedzwiecki, Donna, Elsing, Alicia, Hurwitz, Herbert I., Fakih, Marwan G., Bekaii-Saab, Tanios
Publicado 2022

Cetuximab and Irinotecan With or Without Bevacizumab in Refractory Metastatic Colorectal Cancer: BOND-3, an ACCRU Network Randomized Clinical Trial

por Lipsyc-Sharf, Marla, Ou, Fang-Shu, Yurgelun, Matthew B, Rubinson, Douglas A, Schrag, Deborah, Dakhil, Shaker R, Stella, Philip J, Weckstein, Douglas J, Wender, Donald B, Faggen, Meredith, Zemla, Tyler J, Heying, Erica N, Schuetz, Samantha R, Noble, Stephanie, Meyerhardt, Jeffrey A, Bekaii-Saab, Tanios, Fuchs, Charles S, Ng, Kimmie
Publicado 2022

PSMA as a Theranostic Target in Hepatocellular Carcinoma: Immunohistochemistry and (68)Ga‐PSMA‐11 PET Using Cyclotron‐Produced (68)Ga

por Thompson, Scott M., Suman, Garima, Torbenson, Michael S., Chen, Zong‐Ming E., Jondal, Danielle E., Patra, Anurima, Ehman, Eric C., Andrews, James C., Fleming, Chad J., Welch, Brian T., Kurup, Anil N., Roberts, Lewis R., Watt, Kymberly D., Truty, Mark J., Cleary, Sean P., Smoot, Rory L., Heimbach, Julie K., Tran, Nguyen H., Mahipal, Amit, Yin, Jun, Zemla, Tyler, Wang, Chen, Fogarty, Zachary, Jacobson, Mark, Kemp, Bradley J., Venkatesh, Sudhakar K., Johnson, Geoffrey B., Woodrum, David A., Goenka, Ajit H.
Publicado 2021